3 Growth Companies With High Insider Ownership On Euronext Paris

In This Article:

As the French CAC 40 Index recently added 0.48%, reflecting a cautiously optimistic outlook amid potential European Central Bank rate cuts and economic stimulus from China, investors are keenly observing growth opportunities within the market. In this context, companies with high insider ownership often attract attention for their potential alignment of interests between management and shareholders, making them appealing prospects in a fluctuating economic landscape.

Top 10 Growth Companies With High Insider Ownership In France

Name

Insider Ownership

Earnings Growth

Groupe OKwind Société anonyme (ENXTPA:ALOKW)

20.6%

36%

VusionGroup (ENXTPA:VU)

13.4%

81.7%

Icape Holding (ENXTPA:ALICA)

30.2%

33.9%

Arcure (ENXTPA:ALCUR)

21.4%

26.6%

STIF Société anonyme (ENXTPA:ALSTI)

16.4%

22.9%

La Française de l'Energie (ENXTPA:FDE)

19.9%

31.9%

Munic (ENXTPA:ALMUN)

27.1%

174.1%

Adocia (ENXTPA:ADOC)

11.7%

64%

S.M.A.I.O (ENXTPA:ALSMA)

17.4%

103.8%

MedinCell (ENXTPA:MEDCL)

15.8%

93.9%

Click here to see the full list of 23 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

Let's explore several standout options from the results in the screener.

Exclusive Networks

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Exclusive Networks SA is a global cybersecurity specialist focusing on digital infrastructure, with a market cap of €2.14 billion.

Operations: The company generates revenue from various regions, including €480 million from APAC, €4.19 billion from EMEA, and €705 million from the Americas.

Insider Ownership: 13.1%

Earnings Growth Forecast: 33.5% p.a.

Exclusive Networks is poised for significant earnings growth, forecasted at 33.5% annually, outpacing the French market's 12%. Despite lower profit margins this year, its revenue growth of 13.1% surpasses the market average of 5.6%. The company is valued at €2.2 billion in a proposed acquisition by CD&R and Permira, offering a premium per share price with an exceptional distribution planned. This transaction underscores strong insider ownership and strategic financial restructuring potential.

ENXTPA:EXN Ownership Breakdown as at Oct 2024
ENXTPA:EXN Ownership Breakdown as at Oct 2024

MedinCell

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a pharmaceutical company based in France that specializes in developing long-acting injectables across various therapeutic areas, with a market cap of €446.20 million.

Operations: The company's revenue segment includes Pharmaceuticals, generating €11.95 million.